Menopause Digital Hormone Balancing App Market Report 2026

Menopause Digital Hormone Balancing App Market Overview

• Menopause Digital Hormone Balancing App market size has reached to $1.52 billion in 2025 • Expected to grow to $3.35 billion in 2030 at a compound annual growth rate (CAGR) of 17% • Growth Driver: Rising Smartphone Penetration Driving The Market Growth Due To Expanded Accessibility And User Base • Market Trend: Advanced Clinical Decision-Support Engines Transforming Menopause Management • North America was the largest region in 2025.

What Is Covered Under Menopause Digital Hormone Balancing App Market?

A menopause digital hormone balancing app is a digital platform that helps individuals navigate the hormonal shifts that occur during menopause. It typically includes tools for tracking symptoms, monitoring health patterns, and providing personalized guidance based on individual data. The app uses technology to deliver tailored insights and support, often integrating educational content and lifestyle tips to encourage overall well-being. The main types of menopause digital hormone balancing apps are symptom tracking, hormone monitoring, lifestyle management, educational apps, and others. Symptom tracking is the process of recording and monitoring health signs or changes over time to identify patterns and manage conditions effectively. These apps are available on platforms including the iPhone operating system, Android, and the web, and are offered through subscription models including free, paid, and freemium. The main end-users are women, healthcare providers, clinics, and others.

What Is The Menopause Digital Hormone Balancing App Market Growth Forecast?

The menopause digital hormone balancing app market size is expected to see rapid growth in the next few years. It will grow to $3.35 billion in 2030 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to increasing demand for personalized digital therapeutics, rising integration with wearable health devices, expansion of subscription-based health apps, growing focus on holistic menopause care, increasing adoption of ai-driven health insights. Major trends in the forecast period include increasing adoption of personalized menopause management apps, growing use of symptom tracking and analytics, rising integration of hormone monitoring features, expansion of virtual health coaching services, enhanced focus on user-centric app design.

What Is The Driver Of The Menopause Digital Hormone Balancing App Market?

The increasing smartphone penetration is expected to propel the growth of the menopause digital hormone balancing app market going forward. Smartphone penetration refers to the percentage of a population or target market that owns or actively uses a smartphone. Increasing smartphone penetration is driven by the greater affordability of smartphones, making them accessible to a larger population. Higher smartphone penetration helps menopause digital hormone balancing apps by expanding their potential user base, enabling more women to access symptom tracking, hormone monitoring, lifestyle guidance, and educational resources conveniently on their devices. For instance, in February 2023, according to the GSM Association (GSMA), a UK-based industry organization that represents the interests of mobile network operators and companies, smartphone penetration in sub-Saharan Africa is projected to rise significantly, reaching 87% by 2030, up from 51% in 2022. Therefore, the increasing smartphone penetration is driving the growth of the menopause digital hormone balancing app industry.

Key Players In The Global Menopause Digital Hormone Balancing App Market

Major companies operating in the menopause digital hormone balancing app market are Chorus Health Inc., Noom Inc., Maven Clinic Co., Forth Ltd., Join Olivia AB, Clue by BioWink GmbH, Balance App Ltd., Peppy Health Ltd., Elektra Health Inc., Eli Health Inc., FemTech Health Inc., Health and Her Ltd., Hormona Ltd., Lisa Health Inc., Mira Fertility Inc., Oova Life Inc., Stella LLC, Vira Health Ltd., Wild AI Ltd., Gennev Inc.

Global Menopause Digital Hormone Balancing App Market Trends and Insights

Major companies operating in the menopause digital hormone balancing app market are focusing on developing advanced solutions, such as a clinical decision-support engine, which allows for structured capture of patient data and real-time evaluation against evidence-based menopause pathways to deliver personalized management recommendations at the point of care. Clinical decision-support engine refers to a software system designed to assist healthcare providers in making informed and evidence-based decisions about patient care with structured guidance and recommendations based on patient-specific data. For instance, in July 2025, University College London Hospitals (UCLH), a UK-based healthcare provider specializing in women’s health and menopause care, in collaboration with University College London (UCL), launched the MENO.pause app, a digital clinical decision-support platform designed to assist clinicians in managing patients’ menopause symptoms, and this app integrates evidence-based clinical guidelines from the National Institute for Health and Care Excellence (NICE), the British Menopause Society (BMS), and the British Gynaecological Cancer Society (BGCS) to provide personalized treatment recommendations based on patient history and risk factors. Additionally, the platform facilitates risk stratification for high-risk patients with optimization of hormone replacement therapy (HRT) decisions and streamlines referral pathways for complex or specialist cases within an intuitive workflow-integrated interface suitable for use in primary and secondary care.

What Are Latest Mergers And Acquisitions In The Menopause Digital Hormone Balancing App Market?

In January 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, acquired MenoLabs LLC for an undisclosed amount. With this acquisition, Dr. Reddy's Laboratories aims to accelerate growth in the fast-growing women’s nutritional and wellness markets and complement its U.S. self-care and wellness business by addressing unmet consumer needs for science-based products that relieve menopause symptoms. MenoLabs LLC is a US-based women's health company that offers a menopause digital hormone balancing app.

What Defines the Menopause Digital Hormone Balancing App Market?

The menopause digital hormone balancing app market includes revenues earned by entities by providing services such as mood and sleep tracking, medication guidance, lifestyle coaching, and menstrual cycle tracking. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Menopause Digital Hormone Balancing App Market Report 2026?

The menopause digital hormone balancing app market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the menopause digital hormone balancing app industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.